CURRENT ONCOLOGY, vol.24, no.3, 2017 (SCI-Expanded)
Background Metronomic chemotherapy-administration of low-dose chemotherapy-allows for a prolonged treatment duration and minimizes toxicity for unfit patients diagnosed with advanced non-small-cell lung cancer (NSCLC).